Contact Us

Ortho Evra
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Did you experience any of the following complications during or after using Ortho Evra?

Do you smoke?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Health Canada warning over birth control patch

Nov 24, 2006 | The Canadian Press Health Canada is warning Canadian women that the use of a birth control patch may increase their risk of developing blood clots in the legs and lungs.

The department, along with drugmaker Janssen-Ortho Inc., issued the statement based on research that showed a U.S. formulation of the company's patch contraceptive may be associated with a higher risk of blood clots than oral birth control pills.

"We're taking the precaution of giving people an additional heads up that there's a risk of blood clots with the product," said Health Canada spokesperson Alastair Sinclair.

Janssen-Ortho's U.S. formulation is sold under the brand name Ortho Evra.

The Canadian product, sold as Evra, contains a lower dose of estrogen.

The advisory noted women who are obese are particularly at higher risk of blood clots.

It also points out there is a theoretical risk that exposing the patch to heat could lead to increased exposure of estrogen, so it recommends women wearing an Evra patch avoid saunas and hot tubs.

Sinclair said there have been 78 adverse events reported by Canadian users of Evra since the patch hit the market in 2004. Of those, 14 were cases of blood clots and one was a heart attack.

Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo